Elaboration of gene expression-based clinical decision aids for kidney transplantation: Where do we stand?

Transplantation

Volumn 91, Issue 7, 2011, Pages 691-696

  Brouard, Sophie ^a,b,c   Giral, Magali ^a,b,c   Soulillou, Jean Paul ^a,b,c   Ashton Chess, Joanna ^d  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d TcLand Expression   (France)

Author keywords

Biomarker; Gene expression; Molecular diagnostics

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG MONITORING; GENE EXPRESSION PROFILING; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MEDICAL DECISION MAKING; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION; VALIDATION STUDY;

ACUTE DISEASE; DECISION SUPPORT TECHNIQUES; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PROGNOSIS;

EID: 79954636083     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31820c4559     Document Type: Article

References (28)

1. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
2. Seron D, Moreso F, Bover J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310.
3. Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311.
4. Solez K, Colvin RB, Racusen LC, et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN). Am J Transplant 2007; 7: 518.
5. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donorspecific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804.
6. Foucher Y, Daguin P, Kessler M, et al. How well do pre- and peritransplant variables predict the long-term results of kidney transplantation? Clin Transpl 2008: 113.
7. Reeve J, Einecke G, Mengel M, et al. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009; 9: 1802.
8. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: Small RNAs with big effects. Transplantation 2010; 90: 105.
9. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006; 6: 150.
10. Allanach K, Mengel M, Einecke G, et al. Comparing microarray versus RT-PCR assessment of renal allograft biopsies: Similar performance despite different dynamic ranges. Am J Transplant 2008; 8: 1006.
11. Yannaraki M, Rebibou JM, Ducloux D, et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006; 19: 759.
12. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
13. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
14. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 1475.
15. Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947.
16. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
17. Simon T, Opelz G, Wiesel M, et al. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003; 3: 1121.
18. Ashton-Chess J, Giral M, Mengel M, et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008; 19: 1116.
19. Ashton-Chess J, Mai HL, Jovanovic V, et al. Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection. Kidney Int 2010; 77: 880.
20. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
21. Kurian SM, Heilman R, Mondala TS, et al. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One 2009; 4: e6212.
22. Rodder S, Scherer A, Raulf F, et al. Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009; 9: 517.
23. Scherer A, Gwinner W, Mengel M, et al. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrol Dial Transplant 2009; 24: 2567.
24. Einecke G, Reeve J, Sis B, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010; 120: 1862.
25. Ashton-Chess J, Giral M, et al. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 2007; 84: 1215.
26. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006; 6: 1774.
27. Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448.
28. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010; 362: 1890.